Vectrine
Manufacturer
PT. Dexa Medica, Indonesia
Applicant company
DEXA
Active ingredient
Erdosteine Syr.
Content
175mg/5ml
Shelf life
24 months
Dosage Form
Powder for syrup
Package
Box of 1 bottle of powder for 60ml syrup
Visa Number
VN-19730-16
Issuing Date
23/03/2016
Therapeutic area
Respiratpry/bronchitis
Indication
Mucus loosening and dissolving drugs used in acute and chronic respiratory diseases.
Dosage
Children 15-19 kg: 5 ml, 2 times/day.
Children 20-30 kg: 5 ml, 3 times/day.
Children > 30 kg and adults: 10 ml, 2 times/day.
Maximum treatment time: 10 days
Dosage for patients with mild hepatic impairment:
Dosage should be limited in patients with mild hepatic impairment, to a maximum of 300 mg/day.
Contact
